Hydroxydione
Hydroxydione | |
Hydroxydione sodium succinate | |
| Clinical data | |
|---|---|
| Trade names | Viadril, Predion, Presuren |
| Other names | 21-Hydroxy-5β-pregnane-3,20-dione |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H32O3 |
| Molar mass | 332.484 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Hydroxydione, also known as 21-hydroxy-5β-pregnane-3,20-dione, is a neuroactive steroid which was formerly used as a general anesthetic, but was discontinued due to incidence of thrombophlebitis in patients. It was formulated as the sodium salt of the hemisuccinate ester prodrug hydroxydione sodium succinate (INN, USAN, BAN) and sold under the brand names Viadril, Predion, and Presuren.
Hydroxydione was introduced in 1957, and was the first neuroactive steroid general anesthetic to be introduced for clinical use, an event which was shortly preceded by the observation in 1954 of the sedative properties of progesterone in mice.
Category:
- Drugs not assigned an ATC code